In the News… Teplizumab approved, Twitter mess for Lilly, Medtronic 7-day infusion set launches, and more!
It’s in the News.. the top diabetes stories of the past seven days. This week, the first drug to prevent T1D for any length of time is approved, Eli Lilly takes a financial hit from a Twitter impersonation stunt, Medtronic’s 7-day pump infusion set is ready for consumers, Dexcom’s G7 gets great reviews from older…